These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2054176)

  • 21. Immunohistochemical studies in equine recurrent uveitis (ERU).
    Romeike A; Brügmann M; Drommer W
    Vet Pathol; 1998 Nov; 35(6):515-26. PubMed ID: 9823593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine microemulsion- and mycophenolate mofetil-related lymphoid aggregates are not associated with acute rejection.
    Nast CC; Moudgil A; Zuo XJ; Wilkinson A; Danovitch GM; Jordan SC
    Transplantation; 2001 Jul; 72(2):251-6. PubMed ID: 11477348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine-induced nephrotoxicity in patients with autoimmune uveitis.
    Palestine AG; Austin HA; Nussenblatt RB
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):209-14. PubMed ID: 3927536
    [No Abstract]   [Full Text] [Related]  

  • 24. Basic and clinical immunology in uveitis.
    Nussenblatt RB
    Jpn J Ophthalmol; 1987; 31(3):368-74. PubMed ID: 3430854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute cellular rejection and cyclosporine nephrotoxicity monitored by biopsy in a renal allograft recipient. The differentiation of drug nephrotoxicity from rejection by phenotyping of cellular infiltrates.
    Kolbeck PC; Scheinman JI; Sanfilippo F
    Arch Pathol Lab Med; 1986 May; 110(5):389-93. PubMed ID: 3516116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tubulointerstitial nephritis with uveitis: clinico-pathological and immunological study.
    Litwin M; Michałkiewicz J; Jarmuek W; Woźniewicz B; Grenda R; Iwanicka K; Madaliński K
    Pediatr Nephrol; 2002 Aug; 17(8):683-8. PubMed ID: 12185482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Medical treatment of severe uveitis].
    Berche M; Najjar G; Renard Y; Darwiche A; Musitelli E
    Ophtalmologie; 1989; 3(1):37-9. PubMed ID: 2641067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary peripheral T cell lymphoma in a kidney transplant under immunosuppression with cyclosporine A.
    Ulrich W; Chott A; Watschinger B; Reiter C; Kovarik J; Radaszkiewicz T
    Hum Pathol; 1989 Oct; 20(10):1027-30. PubMed ID: 2529203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal function and blood pressure in patients receiving long-term, low-dose cyclosporine therapy for idiopathic autoimmune uveitis.
    Deray G; Benhmida M; Le Hoang P; Maksud P; Aupetit B; Baumelou A; Jacobs C
    Ann Intern Med; 1992 Oct; 117(7):578-83. PubMed ID: 1524331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic analysis of interstitial infiltrates in kidney allograft biopsies after one year of cyclosporine therapy.
    Versluis DJ; ten Kate FJ; Wenting GJ; Weimar W
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1670-1. PubMed ID: 2496494
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute interstitial nephritis and uveitis syndrome: activated immune cell infiltration in the kidney.
    Yoshioka K; Takemura T; Kanasaki M; Akano N; Maki S
    Pediatr Nephrol; 1991 Mar; 5(2):232-4. PubMed ID: 2031842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A masked, randomized, dose-response study between cyclosporine A and G in the treatment of sight-threatening uveitis of noninfectious origin.
    Nussenblatt RB; de Smet MD; Rubin B; Freidlin V; Whitcup SM; Davis J; Herman D; Bloom JN; Sran PK; Whitcher S
    Am J Ophthalmol; 1993 May; 115(5):583-91. PubMed ID: 8488909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Side effects of systemic cyclosporine in patients not undergoing transplantation.
    Palestine AG; Nussenblatt RB; Chan CC
    Am J Med; 1984 Oct; 77(4):652-6. PubMed ID: 6486141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents.
    Nussenblatt RB; Palestine AG; Chan CC
    Am J Ophthalmol; 1983 Sep; 96(3):275-82. PubMed ID: 6614105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local cyclosporine therapy for experimental autoimmune uveitis in rats.
    Nussenblatt RB; Dinning WJ; Fujikawa LS; Chan CC; Palestine AG
    Arch Ophthalmol; 1985 Oct; 103(10):1559-62. PubMed ID: 3901986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal interstitial cell populations in cyclosporine nephrotoxicity. Identification using monoclonal antibodies.
    Platt JL; Ferguson RM; Sibley RK; Gajl-Peczalska KJ; Michael AF
    Transplantation; 1983 Sep; 36(3):343-6. PubMed ID: 6351377
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclosporine monitoring with levels 6 hours after the morning dose in patients with noninfectious uveitis.
    Rocha G; Deschênes J; Cantarovich M
    Ophthalmology; 1997 Feb; 104(2):245-51. PubMed ID: 9052628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporine nephropathy after heart and heart-lung transplantation.
    Goldstein J; Thoua Y; Wellens F; Leclerc JL; Vanherweghem JL; Vereerstraeten P; Primo G; Toussaint C
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():973-81. PubMed ID: 3921960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of cyclosporine-induced nephrotoxicity by immunoperoxidase analysis of renal allograft biopsies.
    Kolbeck PC; Wolfe JA; Burchette J; Sanfilippo F
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1781-4. PubMed ID: 3547883
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclosporine-induced alterations of humoral response in experimental autoimmune uveitis.
    Chan CC; Palestine AG; Nussenblatt RB
    Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):867-70. PubMed ID: 6234255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.